Venrock to invest $10 million in DURECT - MarketLine Financial Deals

Venrock to invest $10 million in DURECT

Venrock to invest $10 million in DURECT - MarketLine Financial Deals
Venrock to invest $10 million in DURECT
Published Sep 11, 2009
2 pages — Published Sep 11, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

DURECT Corporation, a US-based specialty pharmaceutical company, has agreed to raise $10 million through the issue of 4,444,444 new shares of common stock

  
Source:
Document ID
MA09019_090916
Country
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Venrock to invest $10 million in DURECT" Sep 11, 2009. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Venrock-to-invest-10-million-in-DURECT-2052-8709>
  
APA:
MarketLine Financial Deals. (2009). Venrock to invest $10 million in DURECT Sep 11, 2009. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Venrock-to-invest-10-million-in-DURECT-2052-8709>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.